Skip to main content
Supplement ScienceSupplementScience

Saffron (Macular Health) Research & Evidence

·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence Level

Emerging

Saffron (Macular Health) is emerging as a promising therapeutic option for early age-related macular degeneration (AMD). Falsini et al. (2010) conducted a randomized, double-blind study involving 25 early AMD patients and found that saffron supplementation significantly improved retinal flicker sensitivity compared to placebo over a 3-month period. These findings were further supported by Piccardi et al. (2012), who reported sustained benefits in retinal flicker sensitivity and visual acuity in 29 early AMD patients following 20 mg/day saffron supplementation over 14 months.

Additionally, Marangoni et al. (2013) demonstrated that saffron supplementation improved focal ERG amplitude and sensitivity in early AMD patients, with no influence from CFH or ARMS2 genotypes. This study involved 33 participants and highlighted the potential of saffron as a genotype-independent intervention for macular health.

While the sample sizes in these studies remain relatively small, the consistent positive outcomes across multiple trials underscore the potential of saffron as a beneficial supplement for early AMD patients.

Evidence by Condition

ConditionStudied DoseEvidence
Early AMD support20 mg dailyEmerging
Macular function20-30 mg dailyEmerging
Retinal neuroprotection20 mg dailyPreliminary
Full Saffron (Macular Health) Guide

References

  1. RCTFalsini B, Piccardi M, Minnella A, et al. (2010). Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Investigative Ophthalmology & Visual Science. DOI PubMed
  2. ObservationalPiccardi M, Marangoni D, Minnella AM, et al. (2012). A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration. Evidence-Based Complementary and Alternative Medicine. DOI PubMed
  3. RCTMarangoni D, Falsini B, Piccardi M, et al. (2013). Functional effect of saffron supplementation and risk genotypes in early age-related macular degeneration. Nutrients. DOI PubMed